The genetics of diabetes mellitus

Indian Journal of Medical Research

Volumn 117, Issue JUNE, 2003, Pages 225-238

  Radha, V ^a   Vimaleswaran, K S ^a   Deepa, R ^a   Mohan, V ^a  

^a MADRAS DIABETES RESEARCH FOUNDATION   (India)

Author keywords

Genes; HLA; Insulin resistance; PPAR ; Type 1 diabetes; Type 2 diabetes

Indexed keywords

ADIPONECTIN; CALPAIN 10; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GLUCOKINASE; GLUCOSE TRANSPORTER; GLUCOSE TRANSPORTER 2; GLUCOSE TRANSPORTER 4; HLA ANTIGEN; HLA DQ ANTIGEN; HLA DR ANTIGEN; INSULIN; INSULIN RECEPTOR; INSULIN RECEPTOR SUBSTRATE; INTERLEUKIN 12BETA; INTERLEUKIN 1BETA CONVERTING ENZYME; LEPTIN; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN; MANGANESE SUPEROXIDE DISMUTASE; MITOCHONDRIAL PROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1; PROTEIN; RAT T CELL DIFFERENTIATION ANTIGEN; RESISTIN; SOMATOMEDIN BINDING PROTEIN 2; SOMATOMEDIN BINDING PROTEIN 5; UNCLASSIFIED DRUG; UNCOUPLING PROTEIN 2; UNINDEXED DRUG; ZINC FINGER PROTEIN; ZINC FINGER PROTEIN 236;

CHEMICAL INTERACTION; CHILDHOOD; CHROMOSOME MARKER; CHROMOSOME STRUCTURE; CHRONIC DISEASE; CLINICAL FEATURE; CLUSTER DIFFERENTIATION FACTOR 3 GENE; DIABETES MELLITUS; DISEASE CLASSIFICATION; DISEASE COURSE; ENDOSULPHINE ALPHA GENE; ENVIRONMENTAL FACTOR; EPIDEMIC; FAS ASSOCIATED DEATH DOMAIN GENE; GENE; GENE FUNCTION; GENE LOCATION; GENE LOCUS; GENETIC CORRELATION; GENETIC PREDISPOSITION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENETICS; HEARING IMPAIRMENT; HOMEOBOX D8 GENE; HORMONE ACTION; HUMAN; IMMUNOREGULATION; INDIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN VARIABLE NUMBER OF TANDEM REPEAT GENE; INTERLEUKIN SUPPRESSOR OF LIN 12 LIKE GENE; JK KIDD BLOOD GROUP GENE; MATERNAL DIABETES MELLITUS; MATURITY ONSET DIABETES MELLITUS; MONOCLONAL DUKE UNIVERSITY GENE; NEUROGENIC DIFFERENTIATION GENE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PATHOGENESIS; PATHOPHYSIOLOGY; REVIEW;

DIABETES MELLITUS; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; GENETIC MARKERS; HLA ANTIGENS; HUMANS; INDIA; MODELS, BIOLOGICAL;

EID: 0345330818     PISSN: 09715916     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (85)

1. Bain SC, Kelly AM, Mijovic CH, Barnett AH. Genetic factors in the pathogenesis of Type 1 diabetes. In: Pickup JC, Williams G, editors. Textbook of Diabetes, Oxford: Blackwell Scientific Publications; 1996 p. 15.1-16.1.
2. Froguel P, Vaxillaire M. Genetic factors in the pathogenesis of Type 2 diabetes. In: Pickup JC, Williams G, editors. Textbook of Diabetes, Oxford: Blackwell Scientific Publications; 1996 p. 20.1-21.1.
3. Almawi WY, Tamim H, Azar ST. T helper type 1 and 2 cytokines mediate the onset and progression of type I (insulin-dependent) diabetes. J Clin Endocrinol Metab 1999; 84 : 1497-502.
4. Field LL. Genetic linkage and association studies of type I diabetes - Challenges and rewards. Diabetologia 2002; 745 : 21-35.
5. Akerblom MK, Knip M. Putative environmental factors in type 1 diabetes. Diabetes Metab Rev 1998; 14 : 31-67.
6. Davies JL, Kawaguchi Y, Bennett ST, Copeman JB, Cordell HJ, Pritchard LE, et al. A genome-wide search for human type 1 diabetes susceptibility genes. Nature 1994; 371 : 130-6.
7. Concannon P, Gogolin-Ewens KJ, Hinds DA, Wapelhorst B, Morrison VA, Stirling B, et al. A second-generation screen of the human genome for susceptibility to insulin-dependent diabetes mellitus. Nat Genet 1998; 19 : 292-6.
8. Nerup J, Cathelineau C, Seignalet J, Thomsen M. HLA and endocrine disease. In: Dausset J, Svejgaard A, editors. HLA and Disease. Copenhagen: Munksgaard; 1977 p. 149-61.
9. Nerup J, Platz P, Andersen OO, Christy M, Lyngsoe J, Poulsen JE, et al. HLA antigens and diabetes mellitus. Lancet 1974; ii : 864-6.
10. Owerbach D, Lernmark A, Platz P, Ryder LP, Rask L, Peterson PA, et al. HLA-D region beta-chain DNA endonuclease fragments differ between HLA-DR identical healthy and insulin-dependent diabetic individuals. Nature 1983; 303 : 815-7.
11. Herr M, Dudbridge F, Zavattari P, Cucca F, Guja C, March R, et al. Evaluation of fine mapping strategies for a multifactorial disease locus: Systematic linkage and association analysis of IDDM1 in the HLA region of chromosome 6p21. Hum Mol Genet 2000; 9 : 1291-301.
12. Atkinson MA, Kaufman DL, Newman D, Tobin AJ, Maclaren NK. Islet cell cytoplasmic autoantibody reactivity to glutamate decarboxylase in insulin-dependent diabetes. J Clin Invest 1993; 91 : 350-6.
13. Cox NJ, Wapelhorst B, Morrison VA, Johnson L, Pinchuk L, Spielman RS, et al. Seven regions of the genome show evidence of linkage to type 1 diabetes in a consensus analysis of 767 multiple families. Am J Hum Genet 2001; 69 : 820-30.
14. Mein CA, Esposito L, Dunn MG, Johnson GC, Timms AE, Goy JV, et al. A search for type 1 diabetes susceptibility genes in families from the United Kingdom. Nat Genet 1998; 19 : 297-300.
15. She JX. Susceptibility to type 1 diabetes: HLA-DQ and DR revisited. Immunol Today 1996; 17 : 323-9.
16. Valdes AM, McWeeney S, Thomson G, HLA class II DR-DQ amino acids and insulin-dependent diabetes mellitus-application of the haplotype method. Am J Hum Genet 1997; 60 : 717-28.
17. Lee KH, Wucherpfennig KW, Wiley DC. Structure of a human insulin peptide-HLA-DQ 8 complex and susceptibility to type 1 diabetes. Nat Immunol 2001; 2 : 501-7.
18. Lie BA, Todd JA, Pociot F, Nerup J, Akselsen HE, Joner G, et al. The predisposition to type 1 diabetes linked to the human leukocyte antigen complex includes at least one non-class II gene. Am J Hum Genet 1999; 64 : 793-800.
19. Hitman GA, Tarn AC, Winter RM, Drummond V, Williams LG, Jowett NI, et al. Type 1 (insulin-dependent) diabetes and a highly variable locus close to the insulin gene on chromosome 11. Diabetologia 1985; 28 : 218-22.
20. Hoffman AR, Vu TH. Genomic imprinting. Sci Am 1996; 274 : 52-61.
21. Field LL, Tobias R, Magnus T. A locus on chromosome 15q26 (IDDM3) produces susceptibility to insulin-dependent diabetes mellitus. Nat Genet 1994; 8 : 189-94.
22. Luo DF, Bui MM, Muir A, Maclaren NK, Thomson G, She JX. Affected-sib-pair mapping of a novel susceptibility gene to insulin-dependent diabetes mellitus (IDDM8) on chromosome 6q25-q27. Am J Hum Genet 1995; 57 : 911-9.
23. Zamani M, Pociot F, Raeymaekers P, Nerup J, Cassiman JJ. Linkage of type I diabetes to 15q26 (IDDM3) in the Danish population. Hum Genet 1996; 98 : 491-6.
24. Luo DF, Buzzetti R, Rotteri JI, Maclaren NK, Raffel LJ, Nistico L, et al. Confirmation of three susceptibility genes to insulin-dependent diabetes mellitus: IDDM4, IDDM5, and IDDM8. Hum Mol Genet 1996; 5 : 693-8.
25. Nistico L, Buzzetti R, Pritchard LE, Van Der Auwera B, Giovannini C, Bosi E, et al. The CTLA-4 gene region of chromosome 2q33 is linked to, and associated with type 1 diabetes. Belgian Diabetes Registry. Hum Mol Genet 1996; 5 : 1075-80.
26. Marron MP, Zeidler A, Raffel LJ, Eckenrode SE, Yang JJ, Hopkins DI, et al. Genetic and physical mapping of a type 1 diabetes susceptibility gene (IDDM12) to a 100-kb phagemid artificial chromosome clone containing D2S72-CTLA4D2S105 on chromosome 2q33. Diabetes 2000; 49 : 492-9.
27. Pociot F, McDermott MF. Genetics of type 1 diabetes mellitus. Genes Immun 2002; 3: 235-49.
28. Serjeantson SW, Ranford PR, Kirk RL, Kohonen-Corish MR, Mohan V, Ramachandran A, et al. HLA-DR and -DQ DNA genotyping in insulin-dependent diabetes patients in south India. Dis Markers 1987; 5 : 101-8.
29. Kirk RL, Ranford PR, Serjeantson SW, Thompson AR, Munirathnam Chetty SM, John L, et al. HLA, complement C2,C4 properdin factor B and glyoxalase types in south Indian diabetics. Diabetes Res Clin Pract 1985; 1 : 41-7.
30. Hitman GA, Karir PK, Sachs JA, Ramachandran A, Snehalatha C, Viswanathan M, et al. HLA-D region RFLPs indicate that susceptibility to insulin-dependent diabetes in south India is located in the HLA-DQ region. Diabet Med 1988; 5 : 57-60.
31. Sanjeevi CB, Kanungo A, Shtauvere A, Samal KC, Tripathi BB. Association of HLA class II alleles with different subgroups of diabetes mellitus in eastern India identify different associations with IDDM and malnutrition-related diabetes. Tissue Antigens 1999; 54 : 83-7.
32. Rani R, Sood A, Lazaro AM, Stastny P. Associations of MHC class II alleles with insulin-dependent diabetes mellitus (IDDM) in patients from north India. Hum Immunol 1999; 60 : 524-31.
33. Mehra NK, Kaur G, Kanga U, Tandon N. Immunogenetics of autoimmune diseases in Asian Indians. Ann N Y Acad Sci 2002; 958 : 333-6.
34. Jaini R, Kaur G, Mehra NK. Heterogeneity of HLA-DRB1*04 and its associated haplotypes in the north Indian population. Hum Immunol 2002; 63 : 24-9.
35. Srikanta S, Ahuja MM, Malaviya AN, Mehra NK, Vaidya MC. Type I (insulin-requiring) diabetes mellitus in north India: HLA and autoimmunity. N Engl J Med 1981; 304 : 1175-6.
36. Bhatia E, Mehra NK, Taneja V, Vaidya MC, Ahuja MM. HLA-DR antigen frequencies in a north Indian type I diabetic population. Diabetes 1985; 34 : 565-7.
37. Hales CN. The pathogenesis of NIDDM. Diabetologia 1994; 3 (Sppl 2) : S162-8.
38. Kahn SE. The importance of β-cell failure in the development and progression of Type 2 diabetes. J Clin Endocrinol Metab 2001; 86 : 4047-58.
39. Gerich JE. The genetic basis of type 2 diabetes mellitus: Impaired insulin secretion versus impaired insulin sensitivity. Endocr Rev 1998; 19 : 491-503.
40. Hamman RF. Genetic and environmental determinants of non-insulin-dependent diabetes mellitus (NIDDM). Diabetes Metab Rev 1992; 8 : 287-338.
41. Deffronzo RA, Bonadonna RC, Ferrannini E. Pathogenesis of NIDDM. A balanced overview. Diabetes Care 1992; 15 : 318-68.
42. Howell SL. The mechanism of insulin secretion. Diabetologia 1984; 26 : 319-27.
43. Ferrannini E. Insulin resistance versus insulin deficiency in non-insulin-dependent diabetes mellitus: Problems and prospects. Endocr Rev 1998; 19 : 477-90.
44. Kalsilamdrof N, Tentolouris N. Type 2 diabetes - An overview. In: Pickup JC, Williams G, editors. Text Book of Diabetes. Oxford: Blackwell Scientific Publication; 2003 p. 4.1-5.1.
45. Weyer C, Bogardus C, Mott DM, Pratley RE. The natural history of insulin secretary dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus. J Clin Invest 1999; 104 : 787-94.
46. DeFronzo RA, Prato SD. Insulin resistance and diabetes mellitus. J Diabetes Complications 1996; 10 : 243-5.
47. Fajans SS, Bell GI, Polonsky KS. Molecular mechanisms and clinical pathophysiology of maturity-onset diabetes of the young. N Engl J Med 2001; 345 : 971-80.
48. Mohan V, Ramachandran A, Snehalatha C, Mohan R, Bharani G, Viswanathan M. High prevalence of maturity-onset diabetes of the young (MODY) among Indians. Diabetes Care 1985; 8 : 371-4.
49. Mohan V, Snehalatha C, Ramachandran A, Jayashree R, Viswanathan M. C-peptide responses to glucose load in maturity-onset diabetes of the young (MODY). Diabetes Care 1985; 8 : 69-71.
50. Cao H, Shorey S, Robinson J, Metzeger DL, Stewart L, Cummings E, et al. GKC and HNF -1α mutations in Canadian families with maturity onset diabetes of the young (MODY). Hum Mutat 2002; 20 : 478-9.
51. Cervin C, Orho-Melander M, Ridderstrale M, Lehto M, Barg S, Groop L, et al. Characterization of a naturally occurring mutation (L1O71) in the HNF -1α (MODY 3) gene. Diabetologia 2002; 45 : 1703-8.
52. Aguilar-Salinas CA, Reyes-Rodriguez E, Ordonez-Sanchez ML, Torres MA, Ramirez-Jimenez S, Dominguez-Lopez A, et al. Early-onset type 2 diabetes: Metabolic and genetic characterization in Mexican population. J Clin Endocrinol Metab 2001; 86 : 220-6.
53. Almind K, Doria A, Kahn CR. Putting the genes for type II diabetes on the map. Nat Med 2001; 7 : 277-9.
54. Ji L, Malecki M, Warram JH, Yang Y, Rich SS, Krolewski AS. New susceptibility locus for NIDDM is localized to human chromosome 20q. Diabetes 1997; 46 : 876-81.
55. Olansky L, Welling C, Giddings S, Adler S, Bourey R, Dowse et al. A variant insulin promoter in non-insulin-dependent diabetes mellitus. J Clin Invest 1992; 89 : 1596-1602.
56. Ahlgren U, Jonsson J, Jonsson L, Simu K, Edlund H. Beta-cell-specific inactivation of the mouse Ipf-1/Pdx 1 gene results in loss of the beta-cell phenotype and maturity onset diabetes. Genes Dev 1998; 12 : 1763-8.
57. Yamagata K, Furuta H, Oda N, Kaisaki PJ, Menzel S, Cox NJ, et al. Mutations in the hepatocyte nuclear factor-4alpha gene in maturity-onset diabetes of the young (MODY1). Nature 1996; 384 : 458-60.
58. Hani EH, Clement K, Velho G, Vionnet N, Hager J, Philippi A, et al. Genetic studies of the sulphonylurea receptor gene locus in NIDDM and in morbid obesity among French caucasians. Diabetes 1997; 46 : 688-94.
59. Altshuler D, Hirschhorn JN, Klannemark M, Lindgren CM, Vohl MC, Nemesh J, et al. The common PPAR-gamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes. Nat Genet 2000; 26 : 76-80.
60. Cell FS, Shuldiner AR. The role of peroxisome proliferator-activated receptor gamma in diabetes and obesity. Curr Diab Rep 2002; 2 : 179-85.
61. Almind K, Bjorbaek C, Vestergaard H, Hansen T, Echwald S, Pedersen O. Amino acid polymorphisms of insulin receptor substrate-1 in non-insulin-dependent diabetes mellitus. Lancet 1993; 342 : 828-32.
62. Shepherd PR, Kahn BB. Glucose transporters and insulin action - Implications for insulin resistance and diabetes mellitus. N Engl J Med 1999; 341 : 248-57.
63. Horikawa Y, Oda N, Cox NJ, Li X, Orho-Melander M, Hara M, et al. Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus. Nat Genet 2000; 26 : 163-75.
64. Hara K, Boutin P, Mori Y, Tobe K, Dina C, Yasuda K, et al. Genetic variation in the gene encoding adiponectin is associated with an increased risk of type 2 diabetes in the Japanese population. Diabetes 2002; 51 : 536-40.
65. Simon I, Vendrell J, Gutierrez C, Fernandez-Real JM, Vendrell I, Gallart L, et al. Pro12Ala substitution in the perixosome proliferator-activated receptor-gamma is associated with increased leptin levels in women with type-2 diabetes mellitus. Horm Res 2002; 58 : 143-9.
66. Heo M, Leibel RL, Fontaine KR, Boyer BB, Chung WK, Koulu M, et al. A meta-analytic investigation of linkage and association of common leptin receptor (LEPR) polymorphisms with body mass index and waist circumference. Int J Obes Relat Metab Disord 2002; 26: 640-6.
67. Heo M, Leibel RL, Boyer BB, Chung WK, Koulu M, Karvonen MK, et al. Pooling analysis of genetic data: The association of leptin receptor (LEPR) polymorphisms with variables related to human adiposity. Genetics 2001; 159: 1163-78.
68. Brown JE, Thomas S, Digby JE, Dunmore SJ. Glucose induces and leptin decreases expression of uncoupling protein-2 mRNA in human islets. FEBS Lett 2002; 513: 189-92.
69. McCarthy MI, Hitman GA, Mohan V, Ramachandran A, Snehalatha C, Viswanathan M. The islet amyloid polypeptide gene and non-insulin-dependent diabetes mellitus in south Indians. Diabetes Res Clin Pract 1992; 18: 31-4.
70. Pontiroli AE, Capra F, Veglia F, Ferrari M, Xiang KS, Bell GI, et al. Genetic contribution of polymorphism of the GLUT1 and GLUT4 genes to the susceptibility to type 2 (non-insulin-dependent) diabetes mellitus in different populations. Acta Diabetol 1996; 33: 193-7.
71. Baker WA, Hitman GA, Hawrami K, McCarthy MI, Riikonen A, Tuomilehto-Wolf E, et al. Apolipoprotein D gene polymorphism: A new genetic marker for type 2 diabetic subjects in Nauru and south India. Diabet Med 1994; 11: 947-52.
72. Lepretre F, Vionnet N, Budhan S, Dina C, Powell KL, Genin E, et al. Genetic studies of polymorphisms in ten non-insulin-dependent diabetes mellitus candidate genes in Tamil Indians from Pondicherry. Diabetes Metab 1998; 24: 244-50.
73. Cassell PG, Jackson AE, North BV, Evans JC, Syndercombe-Court D, Philips C, et al. Haplotype combinations of calpain 10 polymorphisms associate with increased risk of impaired glucose tolerance and type 2 diabetes in south Indians. Diabetes 2002; 51: 1622-8.
74. Cassell PG, Neverova M, Janmohamed S, Uwakwe N, Qureshi A, McCarthy MI, et al. An uncoupling protein 2 gene variant is associated with a raised body mass index but not Type II diabetes. Diabetologia 1999; 42: 688-92.
75. Cassell PG, Saker PJ, Huxtable SJ, Kousta E, Jackson AE, Hattersley AT, et al. Evidence that single nucleotide polymorphism in the uncoupling protein 3 (UCP3) gene influences fat distribution in women of European and Asian origin. Diabetologia 2000; 43: 1558-64.
76. Zimmet P, Taylor R, Ram P, King H, Sloman G, Raper LR, et al. Prevalence of diabetes and impaired glucose tolerance in the biracial Melanesian and Indian population of Fiji: A rural-urban comparison. Am J Epidemiol 1983; 118; 673-88.
77. McKeigue PM, Pierpoint T, Ferrie JE, Marmot MG. Relationship of glucose intolerance and hyperinsulinaemia to body fat pattern in south Asians and Europeans. Diabetologia 1992; 35: 785-91.
78. Ramachandran A, Snehalatha C, Latha E, Vijay V, Viswanathan M. Rising prevalence of NIDDM in an urban population in India. Diabetologia 1997; 40: 232-7.
79. Sharp PS, Mohan V, Levy JC, Mather HM, Kohner EM. Insulin resistance in patients of Asian Indian and European origin with non-insulin dependent diabetes. Horm Metab Res 1987; 19: 84-5.
80. Mohan V, Sharp PS, Cloke HR, Burrin JM, Schumer B, Kohner EM. Serum immunoreactive insulin responses to a glucose load in Asian Indian and European Type 2 (non-insulin-dependent) diabetic patients and control subjects. Diabetologia 1986; 29: 235-7.
81. Chandalia M, Abate N, Garg A, Stray-Gundersen J, Grundy SM. Relationship between generalized and upper body obesity to insulin resistance in Asian Indian men. J Clin Endocrinol Metab 1999; 84: 2329-35.
82. Yajnik CS, Lubree HG, Rege SS, Naik SS, Deshpande JA, Deshpande SS, et al. Adiposity and hyperinsulinemia in Indians are present at birth. J Clin Endocrinol Metab 2002; 87: 5575-80.
83. Mohan V, Shanthirani CS, Deepa R, Premalatha G, Sastry NG, Saroja R. Intra-urban differences in the prevalence of the metabolic syndrome in southern India - The Chennai Urban Population Study (CUPS no.4). Diabet Med 2001; 18: 280-7.
84. Deepa R, Shanthirani CS, Premalatha G, Sastry NG, Mohan V. Prevalence of insulin resistance syndrome in a selected south Indian population - The Chennai urban population study-7 [CUPS-7]. Indian J Med Res 2002; 115: 118-27.
85. Vincent S, Planells R, Defoort C, Bernard MC, Gerber M, Prudhomme J, et al. Genetic polymorphisms and lipoprotein responses to diets. Proc Nutr Soc 2002; 61: 427-34.